ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2020

Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.

Hamid Rahmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.